Can PSMA-Targeting Radiopharmaceuticals Be Useful for Detecting Hepatocellular Carcinoma Using Positron Emission Tomography? An Updated Systematic Review and Meta-Analysis

• Asıl Yazarlar: Alessio Rizzo (Yazar), Manuela Racca (Yazar), Domenico Albano (Yazar), Francesco Dondi (Yazar), Francesco Bertagna (Yazar), Salvatore Annunziata (Yazar), Giorgio Treglia (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: MDPI AG, 2022-11-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Background: Several studies proposed the use of positron emission tomography (PET) with Prostate-Specific Membrane Antigen (PSMA)-targeting radiopharmaceuticals in hepatocellular carcinoma (HCC). Our aim is to calculate the detection rate (DR) of this examination in HCC with a meta-analysis. Methods...